Yaskawa

Motoman HC series — Sterile-compatible cobots for sensitive/pharmaceutical environments.

Country
Japan
Ticker
TYO:6506
TYO:6506 Commercial
Coverage
CNEUUS
analytics-pat✓✓✓
Regulatorsfdaemanmpa

Verifiable facts

FactValueSource
Revenue537.7 billion yen (consolidated, FY2024)yaskawa-global.com
Headcount12,833 (consolidated)yaskawa-global.com
Production site28 sites in 12 countries (as of Oct 2025); 29 sites in 13 countries and regions (as of Sep 2025)yaskawa-global.com
CertificationISO 10218-1, ISO 13849-1 (PLd, Cat.3), TÜV-certified Power and Force Limiting (PFL) sensorsmotoman.com · yaskawa.com.tw · yaskawa.de
Regulatory approvalISO 14644-1 (Cleanroom class 4 for HD8, class 5 for HD7), GMP Class A, EHEDG, EN 1672-2, ISO 14159, FDA/EC 1935/2004 compliant materialsyaskawa.co.uk · yaskawa.com.tw · yaskawa.de · yaskawa.eu.com
CapacityExpanding automation via new robot factory in Kitakyushu (scheduled FY2026) and global production base optimization medium confidenceyaskawa-global.com
FundingNot applicable (publicly traded company; consolidated capital 30.6 billion yen as of FY2024)yaskawa-global.com

Independent sources: motoman.com

Technologies
NameClusterRisk
Cobots for bioproductionanalytics-patLow→

Compiled by BIOECON from primary sources.

Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.